Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Short-Term Debt : $2,572 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Short-Term Debt?

Takeda Pharmaceutical Co's Short-Term Debt for the quarter that ended in Dec. 2023 was $2,572 Mil.

Takeda Pharmaceutical Co's quarterly Short-Term Debt declined from Jun. 2023 ($2,949 Mil) to Sep. 2023 ($1,859 Mil) but then increased from Sep. 2023 ($1,859 Mil) to Dec. 2023 ($2,572 Mil).

Takeda Pharmaceutical Co's annual Short-Term Debt increased from Mar. 2021 ($204 Mil) to Mar. 2022 ($1,720 Mil) and increased from Mar. 2022 ($1,720 Mil) to Mar. 2023 ($2,541 Mil).

Takeda Pharmaceutical Co Short-Term Debt Historical Data

The historical data trend for Takeda Pharmaceutical Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Short-Term Debt Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Short-Term Debt

Get a 7-Day Free Trial

8,861.87

5,450.28

203.80

1,720.34

2,540.69

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															2,757.44	2,540.69	2,948.96	1,858.98	2,571.80

Takeda Pharmaceutical Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Takeda Pharmaceutical Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.